The role of apoptosis in bispecific antibody-mediated T-cell cytotoxicity.

por Kroesen, B. J., Wellenberg, G. J., Bakker, A., Helfrich, W., The, T. H., de Leij, L.
Publicado 1996

Immunomodulatory effects of intravenous BIS-1 F(ab')2 administration in renal cell cancer patients.

por Janssen, R. A., Kroesen, B. J., Buter, J., Mesander, G., Sleijfer, D. T., The, T. H., Mulder, N. H., de Leij, L.
Publicado 1995

Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2.

por Kroesen, B. J., Buter, J., Sleijfer, D. T., Janssen, R. A., van der Graaf, W. T., The, T. H., de Leij, L., Mulder, N. H.
Publicado 1994

CD3 directed bispecific antibodies induce increased lymphocyte–endothelial cell interactions in vitro

por Molema, G, Tervaert, J W Cohen, Kroesen, B J, Helfrich, W, Meijer, D K F, Leij, L F M H de
Publicado 2000

Characterization of BIS20x3, a bi-specific antibody activating and retargeting T-cells to CD20-positive B-cells

por Withoff, S, Bijman, M N A, Stel, A J, Delahaye, L, Calogero, A, Jonge, M W A de, Kroesen, B J, Leij, L de
Publicado 2001

Comprehensive analysis of miRNA expression in T-cell subsets of rheumatoid arthritis patients reveals defined signatures of naive and memory Tregs

por Smigielska-Czepiel, K, van den Berg, A, Jellema, P, van der Lei, R J, Bijzet, J, Kluiver, J, Boots, A M H, Brouwer, E, Kroesen, B-J
Publicado 2014